-
Mashup Score: 1AACE 2024 Annual Meeting - 3 day(s) ago
Mark your calendars! AACE Annual Meeting 2024 will be held in New Orleans, Louisiana on May 9-11. Registration coming soon.
Source: pro.aace.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0
Unlock the Power to Transform Lives: Discover the keys to clinically meaningful weight loss thresholds and revolutionize your approach to tackling obesity complications! In our comprehensive program, esteemed faculty members will delve into cutting-edge presentations, including the use of Anti-Obesity Medications (AOM) for significant weight loss, the resolution of obesity complications, and the integration of combination therapies with SGLT-2, GLP-1, and other groundbreaking therapeutics. Gain Knowledge That Transforms Practice!
Source: pro.aace.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 8
Sodium-glucose-cotransporter 2 (SGLT-2) inhibitors are widely used for diabetes management especially because their effects go beyond glucose control. More recently, their indications and usage have expanded to heart failure (HF) and renal dysfunction therapy in patients both with and without diabetes. Beneficial effects, especially for HF readmission, accrue very early in their treatment trajectory, and this has promoted their use in the hospital setting. Data on their safety and efficacy for inpatient use are accumulating but have lagged behind the outpatient data for their use.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 45Sodium-Glucose Cotransporter 2 Inhibitors Should Be Avoided for the Inpatient Management of Hyperglycemia - 4 day(s) ago
Hyperglycemia in patients with type 2 diabetes mellitus is frequently encountered in the hospital setting. The recent guidelines for the management of inpatient hyperglycemia have included the use of dipeptidyl peptidase 4 inhibitors as an alternative to standard insulin therapy in select patients. This raises the question of the inpatient use of sodium-glucose cotransporter 2 inhibitors (SGLT2i), which have gained increasing popularity in the outpatient setting because of beneficial cardiovascular and renal outcomes.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 4Episode 45: Hypoglycemia Care – Putting The AACE Diabetes Clinical Guideline into Practice - 4 day(s) ago
Clinical experts David Lieb, MD, FACE, Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, and Vin Tangpricha, MD, PhD, FACE, discuss the 2022 AACE diabetes guideline updates and address the issue, “How Should Hypoglycemia Be Managed?” Support for this podcast is provided by Xeris Pharmaceuticals, Inc.
Source: pro.aace.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0AACE Advancing Immunizations - 5 day(s) ago
Why are Vaccines Important for Persons with Diabetes? Infections can make it harder to manage diabetes. Even when diabetes is well-managed, infections can be harder to fight. This means that persons with diabetes are at risk for more serious illness and complications. According to the CDC, Some illnesses, like influenza, can raise blood glucose to dangerously high levels. People with diabetes have higher rates of hepatitis B than the rest of the population.
Source: pro.aace.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 1Effect of Christmas Holidays on Type 1 Diabetes Mellitus in Users of Glucose Flash Systems - 5 day(s) ago
Christmas holidays can impact weight and glycemic control in type 2 diabetes, but their effect on type 1 diabetes (T1D) remains understudied. This study assessed how Christmas holidays affect individuals with T1D who use flash continuous glucose monitoring systems.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 1AACE 2024 Annual Meeting - 5 day(s) ago
Mark your calendars! AACE Annual Meeting 2024 will be held in New Orleans, Louisiana on May 9-11. Registration coming soon.
Source: pro.aace.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 43Award Winners - 6 day(s) ago
Dr. Donihi is a professor of pharmacy and therapeutics at the University of Pittsburgh School of Pharmacy. Her clinical practice and research interests focus on inpatient diabetes management, diabetes education, diabetes technology, and facilitation of safe transitions for patients from hospital to home. Dr. Donihi has been a member of the UPMC Diabetes Patient Safety Committee (DPSC) since its inception in 2001, and she has served as co-chair of this system-wide committee since 2010. Through her work
Source: pro.aace.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 1
Puberty blockade and gender-affirming hormone therapy can impair fertility. Counseling on fertility preservation is important before initiation of therapy. Our study aimed to assess Tanner staging and the presence of virilizing secondary sex characteristics at the time of sperm collection and correlate the viability of sperm with the Tanner staging and degree of virilization.
Source: www.endocrinepractice.orgCategories: General Medicine News, EndocrinologyTweet
#AACE2024 Annual Meeting Call for Abstracts Have your work reviewed by experts in the field of endocrinology and showcased at our Annual Meeting in May! Abstract submissions are being accepted through Friday, Dec. 1, 2023, at 11:59 pm EDT. https://t.co/KKbQaOkpq7 #endotwitter